Planning and management to control and eliminate HTLV-1 infection in Iran

被引：6

作者：

Boostani, Reza ^{[1
]}

Lotfinejad, Nasim ^{[2
]}

Zemorshidi, Fariba ^{[1
]}

Vahidi, Zohreh ^{[3
]}

Rezaee, Seyed Abdolrahim ^{[3
]}

Farid, Reza ^{[4
]}

Rafatpanah, Houshang ^{[3
]}

机构：

[1] Mashhad Univ Med Sci, Dept Neurol, Mashhad, Razavi Khorasan, Iran

[2] Mashhad Univ Med Sci, Dept Res, Fac Med, Mashhad, Razavi Khorasan, Iran

[3] Mashhad Univ Med Sci, Inflammat & Inflammatory Dis Div, Immunol Res Ctr, Mashhad, Razavi Khorasan, Iran

[4] Mashhad Univ Med Sci, Allergy Res Ctr, Mashhad, Razavi Khorasan, Iran

来源：

IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES | 2021年 / 24卷 / 03期

关键词：

ATL; HAM/TSP; HTLV-1; Prevention; Treatments; INTERFERON-ALPHA; I INFECTION; SEROPREVALENCE; NORTHEAST;

D O I：

10.22038/ijbms.2021.50803.11562

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Prevention and treatment of the Human T-cell leukemia virus, type 1 (HTLV-1) which was discovered nearly 40 years ago, still remain challenging. The reported high prevalence of HTLV-1 in some countries around the world triggered an open letter to the World Health Organization (WHO), urging action against HTLV1 infection in 2018. This highlights the importance of virus elimination strategies to eradicate HTLV-1 infection. In Iran, we have documented our experiences with the virus in order to achieve and promote the possible ways to manage, control, and eliminate HTLV-1. Although there has been considerable progress apropos of HTLV-1, a series of additional challenges need to be tackled to control HTLV-1 infection in Iran.

引用

页码：264 / 266

页数：3

共 12 条

[1]

Azarpazhooh MR, 2012, AIDS RES HUM RETROV, V28, P895, DOI [10.1089/aid.2011.0248, 10.1089/AID.2011.0248]

[2]

Hedayati-Moghaddam MR, 2013, IRAN J BASIC MED SCI, V16, P196

[3] A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies [J].

Hermine, Olivier ;

Ramos, Juan Carlos ;

Tobinai, Kensei .

ADVANCES IN THERAPY, 2018, 35 (02) :135-152

[4] Impact of clinical registries on quality of patient care and health outcomes: protocol for a systematic review [J].

Hoque, Dewan Md Emdadul ;

Kumari, Varuni ;

Ruseckaite, Rasa ;

Romero, Lorena ;

Evans, Sue M. .

BMJ OPEN, 2016, 6 (04)

[5]

Kalavi K, 2013, IRAN J BASIC MED SCI, V16, P225

[6] Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran [J].

Karimi, Gharib ;

Zadsar, Maryam ;

Pourfathollah, Ali Akbar .

VIROLOGY JOURNAL, 2017, 14

[7] Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL) [J].

Kchour, Ghada ;

Tarhini, Mahdi ;

Kooshyar, Mohamad-Mehdi ;

El Hajj, Hiba ;

Wattel, Eric ;

Mahmoudi, Mahmoud ;

Hatoum, Hassan ;

Rahimi, Hossein ;

Maleki, Masoud ;

Rafatpanah, Houshang ;

Rezaee, S. A. Rahim ;

Yazdi, Mojtaba Tabatabaei ;

Shirdel, Abbas ;

de The, Hugues ;

Hermine, Olivier ;

Farid, Reza ;

Bazarbachi, Ali .

BLOOD, 2009, 113 (26) :6528-6532

[8] Time to eradicate HTLV-1: an open letter to WHO [J].

Martin, Fabiola ;

Tagaya, Yutaka ;

Gallo, Robert .

LANCET, 2018, 391 (10133) :1893-1894

[9] Ciclosporin A Proof of Concept Study in Patients with Active, Progressive HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis [J].

Martin, Fabiola ;

Castro, Hannah ;

Gabriel, Carolyn ;

Adonis, Adine ;

Fedina, Alexandra ;

Harrison, Linda ;

Brodnicki, Liz ;

Demontis, Maria A. ;

Babiker, Abdel G. ;

Weber, Jonathan N. ;

Bangham, Charles R. M. ;

Taylor, Graham P. .

PLOS NEGLECTED TROPICAL DISEASES, 2012, 6 (06)

[10] Towards the elimination of HTLV-1 infection in Japan [J].

Nishijima, Takeshi ;

Shimada, Satoshi ;

Noda, Hiroyuki ;

Miyake, Kuniaki .

LANCET INFECTIOUS DISEASES, 2019, 19 (01) :15-16

← 1 2 →